LYTTON LAURENCE W 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 1:51 pm Sale | 2025-06-30 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 216,840 1.000% | -936,648 (-81.20%) | Filing |
| 2024-02-14 2:42 pm Purchase | 2023-12-31 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 1,153,488 6.800% | 282,307 (+32.41%) | Filing |
| 2023-02-13 3:47 pm Purchase | 2022-12-31 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 871,181 5.300% | 37,876 (+4.55%) | Filing |
| 2022-11-23 2:40 pm Purchase | 2022-11-14 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 833,305 5.100% | 833,305 (New Position) | Filing |